期刊文献+

氟喹诺酮耐药志贺菌中质粒介导qnr基因的检测 被引量:4

The determination of plamid-mediated qnr gene in quinolone-resistant Shigella
下载PDF
导出
摘要 目的检测志贺菌对氟喹诺酮抗菌药物的耐药情况,探讨氟喹诺酮耐药与志贺菌携带质粒介导qnr基因的关系。方法用纸片扩散法对100株志贺菌(福氏志贺菌50株,宋内志贺菌50株)进行耐药性检测,聚合酶链反应(PCR)检测志贺菌质粒介导qnr基因并进行DNA测序,分析qnr基因的存在与药敏结果的关系。结果 100株志贺菌中有9株检出qnr基因,检出率为9%(9/100),福氏志贺菌为4%(2/50),宋内志贺菌为14%(7/50);qnr基因阳性菌株对氧氟沙星的耐药率(11.1%)高于阴性菌株(5.5%),但差异无统计学意义。qnr基因阳性菌株对5种氟喹诺酮药物的抑菌圈中位数比较均缩小。结论宋内志贺菌质粒介导氟喹诺酮耐药qnr基因的携带率明显高于福氏志贺菌;志贺菌若携带质粒介导qnr基因则会导致对氟喹诺酮药物的敏感性下降。 Objective To investigate the quinolone-resistance of Shigella isolates and its relationship with the plamid-mediated qnr gene.Methods A total of 100 Shigella isolates were collected.50 isolates were Shigella flexneri,and 50 isolates were Shigella sonnei.The drug resistance was determined by disc diffusion method.The qnr gene was detected by polymerase chain reaction(PCR).The qnr gene segments were amplified and sequenced to analyze the correlation between quinolone-resistance and the presence of qnr gene.Results The qnr gene was identified in 9(9%)of the 100 Shigella isolates,2(4%)of the 50 Shigella flexneri and 7(14%) of the 50 Shigella sonnei.The resistance rate of ofloxacin in qnr positive isolates(11.1%) was higher than that in qnr negative isolates(5.5%),but there was no statistical significance.The median diameters of 5 quinolone inhibition zones of the isolates with qnr gene were smaller than those without qnr gene.Conclusions The plamid-mediated qnr gene in Shigella sonnei isolates is more than that in Shigella flexneri isolates.The plamid-mediated qnr gene of Shigella isolates can decrease the resistance rate of quinolone.
出处 《检验医学》 CAS 北大核心 2011年第10期645-647,共3页 Laboratory Medicine
关键词 氟喹诺酮耐药 志贺菌 质粒介导qnr基因 Quinolone resistance Shigella Plamid-mediated qnr gene
  • 相关文献

参考文献8

  • 1Kotloff KL,Winickoff JP,Ivanoff B,et al.Global burden of Shigella infections:implications for vaccine development and implementation of control strategies[J].Bull World Health Organ,1999,77(8):651-666.
  • 2Martínez-Martínez L,Pascual A,Jacoby GA.Quinolone resistance from a transferable plasmid[J].Lancet,1998,351 (9105):797-799.
  • 3Hata M,Suzuki M,Matsumoto M,et al.Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b[J].Antimicrob Agents Chemo-ther,2005,49(2):801-803.
  • 4Robicsek A,Sahm DF,Strahilevitz J,et al.Broader distribution of plasmid-mediated quinolone resistance in the United States[J].Antimicrob Agents Chemother,2005,49(7):3001-3003.
  • 5Clinical and Laboratory Standards Institute.Performance standards for antimicrobial susceptibility testing[S].M100-S17,CLSI,2007.
  • 6Martínez-Martínez L,Pascual A,García I,et al.Interaction of plasmid and host quinolone resistance[J].J Antimicrob Chemother,2003,51 (4):1037-1039.
  • 7Rodríguez-Martínez JM,Pascual A,García I,et al.Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type beta-lactamase[J].J Antimicrob Chemother,2003,52(4):703-706.
  • 8王明贵,JohnH.Tran,GeorgeA.Jacoby,张婴元,汪复,DavidC.Hooper.大肠埃希菌临床分离株对喹诺酮类抗菌药的质粒介导耐药[J].中国感染与化疗杂志,2006,6(4):217-221. 被引量:27

二级参考文献9

  • 1朱德妹,汪复,张婴元.2003年上海地区细菌耐药性监测[J].中国抗感染化疗杂志,2005,5(1):4-12. 被引量:147
  • 2Wang F,Zhu DM,Hu FP,et al.Surveillance of bacterial resistance among isolates in Shanghai in 1999[J].J Infect Chemother,2001,7:117-120.
  • 3Hooper DC.Mechanisms of action and resistance of older and newer fluoroquinolones[J].Clin Infect Dis,2000,31 suppl 2:S24-S28.
  • 4Martinez-Martinez L,Pascual A,Jacoby GA.Quinolone resistance from a transferable plasmid[J].Lancet,1998,351:797-799.
  • 5Tran JH,Jacoby GA.Mechanism of plasmid-mediated quinolone resistance[J].Proc Natl Acad Sci USA,2002,99:5638-5642.
  • 6Partridge SR,Brown HJ,Hall RM.Characterization and move ment of the class 1 integron known as Tn2521 and Tn1405[J].Antimicrob Agents Chemother,2002,46:1288-1294.
  • 7Jacoby GA,Chow N,Waites KB.Prevalence of plasmid-mediated quinolone resistance[J].Antimicrob Agents Chemother,2003,47:559-562.
  • 8Verdet C,Arlet G,Barnaud G,et al.A novel integron in Salmonella enterica servovar Enteritidis,carrying the bla(DHA-1) gene and its regulator gene ampR,originated from Morganella morganii[J].Antimicrob Agents Chemother,2000,44:222-225.
  • 9Tavio MM,Vila J,Ruiz J,et al.Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates[J].J Antimicrob Chemother,1999,44:735-742.

共引文献26

同被引文献109

  • 1杜银忠.3种中药对产酶菌R质粒消除作用的研究[J].青海大学学报(自然科学版),2009,27(1):78-81. 被引量:8
  • 2陈群,陈南菊,王胜春.黄连对大肠杆菌R质粒消除作用的实验研究[J].中国中西医结合杂志,1996,16(1):37-38. 被引量:27
  • 3王小平,刘海江,甄蕾,周曾同,李鸣宇,张卫东.松萝酸对金黄色葡萄球菌耐药质粒的消除作用[J].中药材,2006,29(1):36-39. 被引量:17
  • 4苗强,肖洋,何中勤.白头翁提取液对铜绿假单胞菌R质粒的消除作用[J].中药新药与临床药理,2006,17(4):258-259. 被引量:18
  • 5Chenia HY, Pillay B, Pillay D. Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens [ J ]. J Antimicrob Chemother, 2006, 58(6) :1274-1278.
  • 6Ruiz J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection [ J ]. J Antimicrob Chemother, 2003, 51 (5) :1109-1117.
  • 7Shenz Y, Ruiz J, Zarazaga M, et al. Effect of the efflux pump inhibitor Phe-Arg-beta-naphthylamide on the MIC values of the quinolones, tetracycline and chloramphenicol, in Escherichia coli isolates of different origin [ J ]. J Antimicrob Chemother, 2004, 53 ( 3 ) : 544-545.
  • 8Park CH, Robicsek A ,Jacoby GA, et al. Prevalence in the United States of aac (6')-Ib-cr encoding a ciprofloxacin-modifying enzyme [ J ]. Antimicrob Agents Chemother, 2006, 50 ( 11 ) : 3953-3955.
  • 9Robicsek A, Sahm DF, Strahilevitz J, et al. Broader distribution of plasmid-mediated quinolone resistance in the United States [ J ]. Antimicrob Agents Chemother, 2005,49(7) :3001-3003.
  • 10Morgan-Linnell SK, Bethel Boyd L, Steffen D, et al. Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolates [ J ]. Antimicrob Agents Chemother,2009, 53(1 ) :235-241.

引证文献4

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部